![]() 2002 106(6):649–52.īertaglia E, Zoppo F, Bonso A, Proclemer A, Verlato R, Corò L, et al. Contemporary management of atrial flutter. Large prospective RCTs are warranted to confirm the benefit of prophylactic PVI in typical AFL. Our study indicated the efficacy and safety of prophylactic PVI during CTI ablation in typical AFL patients without AF history, especially for elder patients. There is a lower occurrence of AF in prophylactic PVI group (27% versus 46%, OR = 0.45, 95% CI: 0.28 to 0.73 P = 0.001) and no difference of complications between prophylactic PVI group and CTI group (4% versus 2% P = 0.33). In the subgroup of age > 55, prophylactic PVI showed even higher incidence of freedom from AA. More patients in prophylactic PVI group were free from atrial arrhythmias (AA) compared with those in CTI group (69% versus 50%, OR = 2.36, 95% CI: 1.51 to 3.68 P = 0.0001). A total of 357 patients with follow-up of 20 ± 9 months were included. Resultsįour RCTs met the inclusion criteria. Randomized controlled trials (RCT) comparing prophylactic PVI to CTI ablation alone in typical AFL patients without prior documentation of AF were identified in the MEDLINE, EMBASE, and Cochrane databases. The meta-analysis was conducted to evaluate the benefit of prophylactic pulmonary vein isolation (PVI) in typical AFL patients. New-onset atrial fibrillation (AF) is common after cavotricuspid isthmus (CTI)–dependent atrial flutter (AFL) ablation.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |